Sodium alginate and Bone marrow failure - a phase IV clinical study of FDA data

Summary:

Bone marrow failure is reported as a side effect among people who take Sodium alginate (algin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Piperacillin And Tazobactam, and have Mantle cell lymphoma.

The phase IV clinical study analyzes which people have Bone marrow failure when taking Sodium alginate. It is created by eHealthMe based on reports of 1,324 people who have side effects when taking Sodium alginate from the FDA, and is updated regularly.

What is Sodium alginate?

Sodium alginate has active ingredients of algin. eHealthMe is studying from 1,325 Sodium alginate users. Check the latest studies of Sodium alginate.

What is Bone marrow failure?

Bone marrow failure is found to be associated with 1,007 drugs and 1,439 conditions by eHealthMe. Check the latest studies of Bone marrow failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,324 people reported to have side effects when taking Sodium alginate.
Among them, 14 people (1.06%) have Bone marrow failure.

Could Sodium alginate cause Bone marrow failure?

Among these 14 people:

How long have people been on Sodium alginate when they have Bone marrow failure? *

What is the gender of people who have Bone marrow failure when taking Sodium alginate? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Bone marrow failure when taking Sodium alginate? *

What are other drugs people take besides Sodium alginate? *

Sitagliptin: 6 people, 42.86%
Piperacillin And Tazobactam: 6 people, 42.86%
Fluconazole: 4 people, 28.57%
Sulfamethoxazole And Trimethoprim: 3 people, 21.43%
Naproxen: 3 people, 21.43%
Cefepime Hydrochloride: 3 people, 21.43%
Lansoprazole: 3 people, 21.43%
Magnesium Oxide: 3 people, 21.43%
Sucralfate: 3 people, 21.43%
Meropenem: 3 people, 21.43%

What are other side effects people have besides Bone marrow failure? *

Thrombocytopenia (decrease of platelets in blood): 3 people, 21.43%
Fever: 3 people, 21.43%
Cough: 3 people, 21.43%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 21.43%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 21.43%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 21.43%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%
Lymphocyte Count Decreased: 2 people, 14.29%
Hepatic Function Abnormal: 2 people, 14.29%
Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 2 people, 14.29%

What are the existing conditions these people have? *

Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 21.43%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 14.29%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 14.29%
Hypokalemia (low potassium): 2 people, 14.29%
Allergies: 2 people, 14.29%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 14.29%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 14.29%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 1 person, 7.14%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium alginate and have Bone marrow failure?

- Check whether Bone marrow failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sodium alginate:

Sodium alginate (1,325 reports)

Browse all side effects of Sodium alginate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow failure:

Bone marrow failure (1,007 drugs)

Browse all the conditions that are associated with Bone marrow failure:

Bone marrow failure (1,439 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on algin (the active ingredients of Sodium alginate) and Sodium alginate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.